Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.337 EUR | +1.51% | +5.31% | -6.39% |
Apr. 17 | Intrasense: an innovative solution for cancer monitoring | CF |
Apr. 09 | Guerbet: CE certificate for a platform | CF |
Sales 2022 | 3.79M 4.06M | Sales 2023 | 3.3M 3.54M | Capitalization | 18.8M 20.16M |
---|---|---|---|---|---|
Net income 2022 | -3M -3.22M | Net income 2023 | -3M -3.22M | EV / Sales 2022 | 2.85 x |
Net Debt 2022 | 650K 697K | Net cash position 2023 | 3.06M 3.28M | EV / Sales 2023 | 4.76 x |
P/E ratio 2022 |
-2.97
x | P/E ratio 2023 |
-5.16
x | Employees | 74 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.57% |
1 day | +1.51% | ||
1 week | +5.31% | ||
Current month | +46.52% | ||
1 month | +34.80% | ||
3 months | +0.60% | ||
6 months | -23.23% | ||
Current year | -6.39% |
Managers | Title | Age | Since |
---|---|---|---|
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 18-02-11 |
Julien Coste
DFI | Director of Finance/CFO | - | - |
Frédéric Champ
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michèle Lesieur
CHM | Chairman | 65 | 20-10-07 |
Patrice Rullier
BRD | Director/Board Member | 63 | 19-03-14 |
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 18-02-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.337 | +1.51% | 6 660 |
24-04-24 | 0.332 | +1.84% | 12,525 |
24-04-23 | 0.326 | -1.21% | 3,451 |
24-04-22 | 0.33 | +1.54% | 11,327 |
24-04-19 | 0.325 | +1.56% | 60,780 |
Real-time Euronext Paris, April 25, 2024 at 04:41 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-6.39% | 18.52M | |
+8.78% | 220B | |
+8.24% | 185B | |
+11.16% | 133B | |
+26.12% | 107B | |
-0.19% | 62.91B | |
+16.21% | 53.34B | |
-1.63% | 47.71B | |
-1.11% | 40.29B | |
+12.16% | 39.57B |
- Stock Market
- Equities
- ALINS Stock